with T-PLL is also complicated by the inconsistent classi- LGL leukemia is also rare and, unlike T-PLL or ATLL, the 14,15 endemic areas and a variable etiology of T cell diseases.
phenotype has been reported more frequently in Japan. 8 A patients for the presence of HTLV-I/II by serology and molecular techniques using PCR primers against HTLV-II and all parts of the HTLV-I genome. The sensitivity of the technique was Introduction increased by using nested PCR. Reverse transcriptase (RT) activity was also measured in supernatants from peripheral The human T cell lymphotropic virus type I (HTLV-I) was first blood mononuclear cells (PBMCs) in short-term culture (STC). isolated from a patient with a mature CD4 + T cell lymphoproliferative disorder subsequently diagnosed as adult T cell leukemia/lymphoma (ATLL).
1 A related retrovirus, HTLV-II, Patients and methods was later isolated from cell lines from two patients thought to have a T cell variant of hairy cell leukemia. 2, 3 This led to a hunt for the retrovirus in other mature T cell lymphoproliferPatients ative disorders. A few groups have reported the presence of HTLV-I sequences in seronegative cases of cutaneous T cell T-PLL is a lymphoproliferative disorder of mature (TdT+) T lymphoma (CTCL), although the proportion of positive cases cells characterized by splenomegaly, lymphadenopathy, fredocumented varies widely and findings remain controquent skin involvement and circulating abnormal prolymphoversial. 4 ,5 T prolymphocytic leukemia (T-PLL) shares some cytes (often greater than 200 × 10 9 /l) whose phenotype is usuclinical and histopathological features with ATLL, namely skin ally CD4 + CD8
− . The diagnostic features of LGL leukemia are infiltration, aggressive course and a CD4
+ phenotype of maliga sustained lymphocytosis Ͼ4 × 10 9 /l with Ͼ80% of lymphonant lymphocytes in two-thirds of cases.
6 However, T-PLL is cytes showing prominent azurophilic granules, neutropenia or a rare disorder representing only around 3% of mature B and other cytopenia not related to heavy bone marrow infiltration, T cell leukemias 7 and few cases have been studied for eviand predominance of a discrete T cell or natural killer subset dence of HTLV-I or -II infection using a range of sensitive techby membrane marker analysis, commonly CD3 one T-PLL case from Brazil. All patients had circulating leu- Table 1 . For nested PCR, 5 l of first round product were used in the second DNA was extracted from fresh PBMCs, PBMCs stored at −80°C and PBMCs after STC. Total DNA was isolated by proround PCR. Positive controls used were DNA from ATLL patients PBMCs, from the HTLV-I-positive cell line C91/PL 18 teinase K digestion followed by standard phenol/chloroform extraction. Quality of DNA was assessed by PCR using priand the HTLV-II-positive C1218 cell line. 19 Negative controls were sterile water and DNA from an HTLV-negative T cell mers for a single copy gene, the endogenous retrovirus sequence ERV-3, 16 and only samples positive in this assay line, MOLT-4. 20 The sensitivity of PCR was determined by serial dilution of DNA from the cell line C10/PBL, which contains were further processed.
DNA was analyzed for HTLV-I/II by simple PCR using prione copy of HTLV-I per cell, 21 and of C1218 DNA in an HTLV-negative DNA (Figure 1a) . mers for HTLV-I gag, HTLV-I/II pol and HTLV-II gag, and by nested PCR using primers for HTLV-I env, LTR and tax Contamination was an initial problem with the PCR, especially when using nested primers but was eliminated by (Table 1) Table 1) , and for HTLV-II, from 4-400 pg of C1218 These were established by incubating 10 5 PBMCs/ml RPMI-1640 medium (Gibco, Paisley, UK) with 20% fetal calf serum, DNA. The RT assay was able to detect 10 −4 units of MLV RT (Figure 2a ). antibiotics and 1:100 phytohemaglutinin at 37°C. 10% interleukin-2 was added at 48-72 h and cells and supernatants PCR with all HTLV-I and -II primer pairs was negative in 181 DNA samples from the 64 cases (Figure 1b) . No RT were harvested at weekly intervals for 1-10 weeks and stored at −80°C until use.
activity was detected in 117 supernatant samples from shortterm cultures of PBMCs from the 64 cases, while RT activity was clearly detected in STCs of PBMCs from a patient with ATLL ( Figure 2b ).
Reverse transcriptase (RT) assay
An RT-PCR-based assay 22 was used to analyze pelleted material derived from ultracentrifugation of supernatants from Discussion short-term patient PBMC cultures. Supernatant from fresh ATLL samples cultured under identical conditions to patient Our findings do not provide evidence of HTLV-I/II infection in 64 cases of T-PLL and LGL leukemia, all but one of whom PBMCs, and purified murine leukemia virus (MLV) RT provided positive controls for the RT assay, and for negative originated from an HTLV-I nonendemic are a, and are consistent with those of some other groups, summarized in Table 2 . controls, water was added instead of cDNA. Conditions, all PCR reactions started with 5-min denaturation at 94°C and finish with 5-10 min extension at 72°C: all temperatures in°C and times in s. All the 43 patients tested were HTLV-I and -II seronegative role of the virus in the pathogenesis of T-PLL or LGL leukemia would be unlikely. and we failed to demonstrate HTLV-I/II pol sequences, HTLV-I gag, env or LTR, or HTLV-II gag sequences in fresh and culThe current study is the largest analysis of HTLV-I/II infection in T-PLL and our results are in agreement with those in tured peripheral blood lymphocytes from the 64 cases. In addition, no RT activity was detected in supernatants from 48 of the 50 cases of T-PLL studied previously. 6,23-27 Twentyseven cases tested previously at this institution were HTLV-I PBMCs in short-term culture.
False negative results in our study are unlikely. Unlike preseronegative but DNA was not analyzed. 6 All 13 cases of 'Thelper phenotype T-CLL' reported by Pandolfi et al, 23 some of vious studies, we included primers against all regions of the HTLV-I genome. The sensitivity of techniques used here was which probably represented T-PLL, were HTLV-I/II seronegative and had no evidence of HTLV-I or -II infection by Southequal to or greater than that of other groups due to the use of nested PCR and the application of such technology to cultured ern blotting. Five seronegative cases of T-PLL from Brazil, an area in which HTLV-I is endemic, were also negative for PBMCs followed by a highly sensitive PCR-based RT assay should have allowed detection of any culturable retrovirus HTLV-I by serology, Southern blotting and PCR 24 and three French cases with an unusual CD8 + phenotype were negative distinct from HTLV-I/II. If the HTLV-I/II retrovirus were present at levels below the lowest limit of detection here, ie one for both HTLV-I and -II by Southern hybridization and PCR (Table 2) . 25 HTLV-I/II infection has been reported in only two HTLV-I/II positive cell in 300 000 cell equivalents, a direct cases of T-PLL but the evidence is not convincing. 26, 27 In one cation of partial or defective proviral sequences improbable. Other possible explanations for positive antibody results case, although atypical lymphoid cells were seen in the peripheral blood, the case presented with leukopenia and proinclude cross-reaction with a different but related virus or cross-reaction due to immune complexes and rheumatoid facgressed slowly, 26 features which are not typical of T-PLL, 6 and HTLV-II antibodies were detected by ELISA only without contor which are common in patients with LGL leukemia. Starkebaum's group controlled for the latter possibility by inclusion firmatory Western blotting. Molecular studies were not performed. 26 In the other case, HTLV-II antibodies were detected by of a group of patients with rheumatoid arthritis and other autoimmune diseases, none of whom had Western blot reactivity. 9 enzyme immunoassay alone and RT activity was detected in the supernatant of cell cultures. 27 Details of methodology are There have been other reports documenting molecular evidence of HTLV-I and -II infection in a few patients with LGL not given in this latter report but most RT assays used at this time relied on the demonstration of enzyme activity, eg by leukemia, many of whom were seronegative like those in the current study (Table 2) , but without the demonstration of clonincorporation of radiolabeled dNTPs, and were prone to false positives due to interference from cellular polymerases.
ality of HTLV-I/II proviral integration in the neoplastic cells. 29, [31] [32] [33] [34] For example, in the largest study of HTLV-II in Again, in keeping with our results, two groups found no serological or molecular evidence of HTLV infection in LGL
LGL leukemia, HTLV-II tax and pol sequences were found by PCR and hybridization in 1/51 patients, but clonal proviral leukemia in seven cases from Brazil (HTLV-I) and 27 cases from France (HTLV-I and-II). 24, 25 In addition, serological studintegration was not shown. 32 In one study in which the infected cell was examined, HTLV-II was shown to be inteies failed to demonstrate HTLV-I antibodies in 11 LGL cases from a nonendemic area of Japan.
8 Although other groups grated in the normal CD3 + CD8 + cells but not in the expanded neoplastic large granular cell population of NK phenotype report evidence for HTLV-I or -II infection in LGL leukemia (Table 2) , there is only one case with convincing demon-(CD3 − CD16 + ).
29
In summary, our findings do not support a role for HTLV-I stration of clonal integration of either retrovirus in the neoplastic cells. 28 In this patient, a case of LGL leukemia was associaor -II in T-PLL or LGL leukemia. However, a retrovirus related to HTLV-I or -II or an as yet unidentified unrelated virus ted with pure red cell aplasia and clonality of the LGLs was shown by T cell receptor gene rearrangement.
28 HTLV-I p19 remains a possible etiological factor in these rare T cell lymphoproliferative disorders. and p24 antibodies were demonstrated in serum and p19 and p24 antigens on PBMCs by immunofluorescence. PCR was not performed but the expression of HTLV-I genomic sequences was shown by RNA dot blot and clonality of proAcknowledgements viral integration demonstrated by Southern blot. 28 RT activity was also detected in supernatants from cultured patient RP was supported by a Leukemia Research Fund Clinical FelPBMCs and C-type retroviral particles were identified at eleclowship; PHLS Virus Reference Laboratory, Colindale, London tron microscopy budding from cultured PBMCs. Although for serological assays of HTLV-I/II. TFS received support from some of these data cannot be taken as definitive proof of the Medical Research Council. HTLV involvement, for example, the serological results do not fulfil the currently accepted criteria for diagnosis of HTLV-I infection (see below) and RT assay used conventional methodReferences ology, the molecular results in this case are convincing. The source of HTLV-I infection in this patient was unclear: his 1 Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JA, Gallo RC. ethnic origin was not detailed but the patient had received Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T cell lymblood transfusions 18 months before presentation. disease. 29 LGL lymphocytosis may be reactive to a number of viral genome in the current study makes failure of amplifi-
